• Myriocin as a Serine Palmitoyltransferase Inhibitor: Protoco

  2026-05-25

  Myriocin, a highly potent serine palmitoyltransferase inhibitor, is redefining workflows in sphingolipid metabolism and cancer research. This article demystifies its practical utility, protocol optimization, and troubleshooting, with actionable guidance for translational experiments.

• Toremifene Citrate: Applied Protocols for Estrogen Receptor

  2026-05-24

  Toremifene Citrate, a rigorously characterized oral selective estrogen receptor modulator, enables precise control of estrogen receptor signaling in breast cancer and endocrinology research. This article distills best practices, stepwise workflows, and troubleshooting strategies for maximizing reproducibility and biological insight with APExBIO’s trusted Toremifene Citrate.

• Probenecid as a Neuroprotective Modulator: Mechanisms and Re

  2026-05-23

  Explore the multifaceted roles of Probenecid in neuroprotection and multidrug resistance reversal. This article provides advanced insight into 4-(dipropylsulfamoyl)benzoic acid’s unique mechanisms and practical assay guidance, surpassing standard workflow summaries.

• Cisapride (R 51619): Powering Cardiac Electrophysiology Rese

  2026-05-22

  Cisapride (R 51619) is the gold standard for modeling hERG channel inhibition and 5-HT4 receptor signaling in advanced cardiac electrophysiology research. Its integration into deep learning-enabled phenotypic screens with iPSC-derived cardiomyocytes sets a new benchmark for predictive cardiotoxicity assessment and protocol reproducibility.

• Targeting DHHC9-Mediated Palmitoylation Suppresses Metastasi

  2026-05-22

  This study identifies DHHC9-mediated palmitoylation of STRN4 as a driver of YAP-dependent cancer metastasis, establishing a novel molecular axis in adenocarcinoma progression. Pharmacological inhibition of DHHC9, using newly identified small molecules, effectively reduces cancer cell migration, suggesting new avenues for anti-metastatic strategies.

• Aclacinomycin A: Applied Protocols for DNA Damage Assays

  2026-05-21

  Aclacinomycin A (Aclarubicin) is a dual topoisomerase inhibitor that delivers high-precision DNA damage induction and apoptosis workflows for cancer research. This article translates the latest nucleolar DNA damage insights and validated cytotoxicity data into actionable experimental strategies, troubleshooting guidance, and comparative advantages using APExBIO’s trusted supply.

• Peroxynitrite-Driven Necroptosis in Cardiac Microvascular In

  2026-05-21

  Liu et al. provide mechanistic evidence linking hyperhomocysteinemia to cardiac microvascular ischemia–reperfusion injury via peroxynitrite-induced ER stress and Ca2+ dysregulation. Their work identifies IP3R-mediated Ca2+ transfer as a pivotal trigger for necroptosis in endothelial cells, with implications for targeted intervention in acute cardiovascular events.

• HSP90 Inhibition Destabilizes METTL3, Suppressing MYC in CRC

  2026-05-20

  This study uncovers how HSP90 stabilizes the RNA methyltransferase METTL3, sustaining MYC mRNA m6A modification and expression in colorectal cancer. Inhibiting HSP90 with 17-AAG promotes METTL3 degradation, diminishing MYC signaling and impairing tumor cell phenotypes, thereby identifying the HSP90-METTL3 axis as a promising therapeutic target.

• Mechanistic Mastery: Advancing cDNA Synthesis for Translatio

  2026-05-20

  Explore how the HyperScript™ First-Strand cDNA Synthesis Kit redefines first-strand cDNA synthesis for translational researchers. This thought-leadership article delves into the molecular constraints of reverse transcription, the impact of overcoming RNA secondary structure barriers, and how mechanistic innovation—anchored in both literature and product intelligence—enables more reliable gene expression profiles. Drawing on recent discoveries in fruit abscission and leveraging comparisons with competitive solutions, we provide strategic guidance for researchers seeking high-fidelity, reproducible data in PCR and qPCR workflows.

• Cy3-UTP: Enabling High-Fidelity RNA Nanoparticle Engineering

  2026-05-19

  Explore how Cy3-UTP empowers advanced RNA nanoparticle engineering and fluorescence imaging. This article uniquely connects Cy3-modified uridine triphosphate to structural insights for high-sensitivity RNA assays and delivery system design.

• Adenosine Triphosphate (ATP): Core Mechanisms and Research U

  2026-05-19

  Adenosine triphosphate (ATP) functions as the universal energy currency and a key regulator of cellular and extracellular signaling. High-purity ATP from APExBIO (SKU C6931) supports precise metabolic and receptor studies. Recent advances reveal ATP’s direct and indirect roles in mitochondrial regulation and purinergic signaling.

• Gap26: Redefining Connexin 43 Blockade for Translational Imp

  2026-05-18

  Gap26, a selective connexin 43 mimetic peptide, offers translational researchers a mechanistically precise, validated approach for dissecting and modulating gap junction signaling. By integrating recent findings on mitochondrial transfer in liver graft protection and established best practices in vascular and neuroprotection research, this article provides strategic and evidence-based guidance for advanced experimental design. APExBIO’s Gap26 is highlighted as a research tool of choice, with protocol recommendations and insights that bridge mechanistic understanding to actionable workflows.

• Tivozanib (AV-951): Redefining Anti-Angiogenic Precision in

  2026-05-18

  This thought-leadership article explores how Tivozanib (AV-951) advances anti-angiogenic therapy for renal cell carcinoma (RCC) and other solid tumors. By integrating mechanistic insights, in vitro evaluation strategies, and clinical outcomes, it provides translational researchers with actionable guidance for experimental design and therapeutic innovation. The discussion is grounded in the latest evidence, bridging robust VEGFR pathway inhibition with workflow optimization and outperforming conventional product-centric resources.

• VX-765 and Blood-Brain Barrier Repair: Advanced Caspase-1 In

  2026-05-17

  Explore how VX-765, a potent caspase-1 inhibitor, uniquely supports blood-brain barrier repair and inflammation resolution. This in-depth analysis links mechanistic innovation to practical assay design, offering fresh insight beyond standard inflammation research.

• Midecamycin: Mechanism, Efficacy, and Application in Antibio

  2026-05-16

  Midecamycin, an acetoxy-substituted macrolide antibiotic, inhibits bacterial protein synthesis by targeting the 23S rRNA. It is highly effective against Gram-positive bacteria and resistant to glycosylation-mediated inactivation. This product from APExBIO enables reproducible antibacterial research workflows.

451 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page